Search Results - "Kaur, Nirmaljot"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Impact of colchicine on mortality and morbidity in COVID-19: a systematic review by Sanghavi, Devang, Bansal, Pankaj, Kaur, Ikwinder Preet, Mughal, Mohsin Sheraz, Keshavamurthy, Chandana, Cusick, Austin, Schram, Jennifer, Yarrarapu, Siva Naga S., Giri, Abhishek R., Kaur, Nirmaljot, Moreno Franco, Pablo, Abril, Andy, Aslam, Fawad

    Published in Annals of medicine (Helsinki) (31-12-2022)
    “…Colchicine, because of its anti-inflammatory and possible anti-viral properties, has been proposed as potential therapeutic option for COVID-19. The role of…”
    Get full text
    Journal Article
  3. 3

    Risks of hypertension and thromboembolism in patients receiving bevacizumab with chemotherapy for colorectal cancer: A systematic review and meta‐analysis by Chitkara, Akshit, Kaur, Nirmaljot, Desai, Aditya, Mehta, Devanshi, Anamika, Fnu, Sarkar, Srawani, Gowda, Nandini, Sethi, Prabhdeep, Thawani, Rajat, Chen, Emerson Y.

    Published in Cancer medicine (Malden, MA) (01-12-2023)
    “…Background Guidelines show that for metastatic colorectal cancer (mCRC), a combination of three‐drug regimens, fluorouracil, leucovorin, and oxaliplatin and…”
    Get full text
    Journal Article
  4. 4

    Presentation and Spectrum of Male Breast Cancer in a Rural Cancer Center in a Subunit of Tata Memorial Center, India by Khandelwal, Sachin, Goel, Priyanka, Sharma, Rakesh, Sancheti, Sankalp, Chaudhary, Debashish, Goel, Alok, Dora, Tapas, Kaur, Nirmaljot, Kapoor, Rakesh

    Published in Indian journal of surgical oncology (01-06-2021)
    “…This is a retrospective study of the incidence and clinical profile of male breast cancer (MBC) presenting to a rural cancer center in Punjab, India. All MBC…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A meta-analysis of bevacizumab’s cardiovascular risks in patients treated for colorectal cancer by Chitkara, Akshit, Desai, Aditya, Mehta, Devanshi, Kaur, Nirmaljot, Anamika, Fnu, Desai, Darshi, Thawani, Rajat

    Published in Journal of clinical oncology (01-02-2023)
    “…113 Background: Bevacizumab (BVZ), a recombinant humanized monoclonal IgG antibody, is commonly used as first- and second-line adjuvant therapy in metastatic…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10

    Abstract 13656: Outcomes of Pre-existing Cardiovascular Disease Amongst COVID-19 Patients by Shah, Chail, Singh, Harmandeep, Martin, Mehwish, Yousuf, Salma, Raval, Payu, Kaur, Nirmaljot, Nwodika, Chika, Yogarajah, Angelina, Subhedar, Rashmi, Rakholiya, Jigisha, Patel, Urvish K

    Published in Circulation (New York, N.Y.) (17-11-2020)
    “…IntroductionCOVID-19 has multiorgan involvement and it is believed that outcomes are poor amongst patients with hypertension (HTN) and pre-existing…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Hydroxychloroquine: A review of its safety and efficacy in COVID-19 by Karia, Rutu H., Nagraj, Sanjana, Gupta, Ishita, Barua, Amit, Kaur, Nirmaljot, Singh, Harmandeep

    “…SARS-CoV-2 is a novel virus that has infected millions of people across the world. Given the compelling need to develop a therapeutic strategy,…”
    Get full text
    Journal Article
  13. 13

    Novel Management of Depression Using Ketamine in the Intensive Care Unit by Giri, Abhishek R., Kaur, Nirmaljot, Yarrarapu, Siva Naga S., Rottman Pietrzak, Kathleen A., Santos, Christan, Lowman, Philip E., Niaz, Shehzad, Franco, Pablo Moreno, Sanghavi, Devang K.

    Published in Journal of Intensive Care Medicine (01-12-2022)
    “…Background: Ketamine, a dissociative anesthetic, induces improvement in depressive symptoms by antagonizing glutaminergic NMDA receptors. Ketamine has been…”
    Get full text
    Book Review Journal Article
  14. 14

    Epidemiological and Clinical Characteristics of 6635 COVID-19 Patients: a Pooled Analysis by Kaur, Nirmaljot, Gupta, Ishita, Singh, Harmandeep, Karia, Rutu, Ashraf, Aisha, Habib, Anam, Patel, Urvish K., Malik, Preeti

    “…An unidentified pneumonia outbreak was first observed in Wuhan, the capital of Hubei Province, China, in December 2019. WHO officially named the disease,…”
    Get full text
    Journal Article
  15. 15
  16. 16